Targeting anti-nephrin antibodies may mitigate recurrence of focal segmental glomerulosclerosis (FSGS) after kidney transplantation, with serial monitoring offering a clinically a ...

CT angiography of the abdomen showed occlusion of the proximal left main renal artery with global hypoperfusion of the left kidney (arrow). A ...

Most obesity drugs do not improve quality of life or heart health, according to a review published online July 8 in The BMJ. Kailei Nong, from Sichuan University in Chengdu, China, and colleagues ...

The TROG 08.03 RAVES randomized controlled trial substudy examined quality of life after post-prostatectomy radiation therapy.

Mean total annual payment increased from $4,936 to $6,722 and from $2,651 to $6,811 for those with and without diabetes, respectively.

A trial of MRI-targeted prostate biopsy compared cognitive fusion and software-based fusion for detection of clinically significant prostate cancer.

No comparative advantage of GLP-1 RA over SGLT2is or DPP4is observed in any of the subgroups. (HealthDay News) — For veterans with type 2 diabetes (T2D) receiving basal insulin therapy, the addition ...

Obinutuzumab beta, particularly at a dose of 1000 mg every 6 months, may improve renal response in patients with lupus nephritis already receiving standard therapies. Obinutuzumab beta dosed at 1000 ...

In this small cohort of adolescents with severe and/or refractory AAV, no drug-induced liver injuries nor opportunistic or serious infections were reported following treatment with avacopan.

Investigators pooled data from 4 trials to evaluate risk for recurrence in patients with intermediate risk non-muscle-invasive bladder cancer.

The FDA has granted traditional approval to Fabhalta (iptacopan) to slow kidney function decline in adults with primary IgA nephropathy at risk of progression.